Can someone circulate the brief without first rewriting the question, the stake, or the review path?
Sample decision brief
Read the brief before the website commentary around it.
This is the closest public proof of the core product: a redacted composite of the brief a pharma team could circulate for one active access decision.
Judge whether it feels forwardable, specific enough to challenge, and clear enough to revisit if the case changes.
Judge it quickly
If the brief fails these tests, the fit is probably weak.
The sample should feel usable as an internal review document, not just readable as marketing proof.
Is it obvious what the team is being asked to review, where the call applies, and where it does not?
Does the brief say what would force the team to narrow, stop, or revisit the call if the case changes?
Inside the brief
What the brief includes.
What exactly is being reviewed, where it applies, and where it explicitly does not apply.
What the team could reasonably rely on at that moment, and which sources actually support the case.
What waiting costs in cycle-time, leakage, utilization, or contract value over a defined window.
Guardrails, breach triggers, and a clear path back to the previous approach if the judgment does not hold up.
How it gets used
The brief is valuable only if it can carry the review and the re-review.
The job is not just to write the brief. The job is to help the team reach a defensible judgment and return to the same frame if the facts move.
Name the move, the business stake, and the scope of the decision.
Circulate one shared document with evidence, scope, uncertainty, and safeguards.
Proceed, limit the scope, ask for more support, or stop.
Return to the same brief if a contradiction, breach, or new evidence changes the judgment.
The brief only earns trust if it can survive first review and later re-review in the same frame.
Next step
If your team would not circulate a brief like this, the fit is probably weak.
If it does look usable, the next question is whether your active decision is narrow enough to scope the first review without a long intake loop.